Literature DB >> 14993811

Polycyclic aromatic hydrocarbon increases mRNA level for interleukin 1 beta in human fibroblast-like synoviocyte line via aryl hydrocarbon receptor.

Ayako Tamaki1, Hidetoshi Hayashi, Hironori Nakajima, Takemasa Takii, Daichi Katagiri, Keiji Miyazawa, Kunitaka Hirose, Kikuo Onozaki.   

Abstract

Rheumatoid arthritis (RA) is characterized by proliferation of synoviocytes that produce proinflammatory cytokines, which is implicated in the pathogenesis of the disease. Among the cytokines, IL-1 is the critical mediator of the disease. When human fibroblast-like synoviocytes line, MH7A, was treated with 3-methylcholanthrene (3-MC), a polycyclic aromatic hydrocarbon (PAH), mRNA of IL-1beta was up-regulated. MH7A cells express functional aryl hydrocarbon receptor (AhR) as shown by 3-MC-inducible CYP1A1 mRNA expression. The effect of 3-MC was inhibited by alpha-napthoflavone, an AhR antagonist, indicating that the effect of 3-MC is mediated via AhR. Benzo[a]pyrene (B[a]P) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) also up-regulated mRNA level of IL-1beta in the cells via AhR. As PAHs are much contained in cigarette smoke, these findings provide the possible basis for epidemiological studies indicating a strong association between heavy cigarette smoking and outcome of RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993811     DOI: 10.1248/bpb.27.407

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  13 in total

Review 1.  The emerging role of aryl hydrocarbon receptor in the activation and differentiation of Th17 cells.

Authors:  Eszter Baricza; Viola Tamási; Nikolett Marton; Edit I Buzás; György Nagy
Journal:  Cell Mol Life Sci       Date:  2015-10-28       Impact factor: 9.261

Review 2.  Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance.

Authors:  Alevtina Y Grishanova; Maria L Perepechaeva
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

3.  Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes.

Authors:  Tejas S Lahoti; Kaarthik John; Jarod M Hughes; Ann Kusnadi; Iain A Murray; Gowdahalli Krishnegowda; Shantu Amin; Gary H Perdew
Journal:  Ann Rheum Dis       Date:  2013-01-24       Impact factor: 19.103

Review 4.  A critical comparison of murine pathology and epidemiological data of TCDD, PCB126, and PeCDF.

Authors:  Katsuhiko Yoshizawa; Allison Heatherly; David E Malarkey; Nigel J Walker; Abraham Nyska
Journal:  Toxicol Pathol       Date:  2007-12       Impact factor: 1.902

Review 5.  Aryl hydrocarbon receptor and experimental autoimmune arthritis.

Authors:  Nam Trung Nguyen; Taisuke Nakahama; Tadamitsu Kishimoto
Journal:  Semin Immunopathol       Date:  2013-08-27       Impact factor: 9.623

6.  Allelic variants of the aryl hydrocarbon receptor differentially influence UVB-mediated skin inflammatory responses in SKH1 mice.

Authors:  Kayla J Smith; Iain A Murray; Jacob A Boyer; Gary H Perdew
Journal:  Toxicology       Date:  2017-11-29       Impact factor: 4.221

7.  Immunomodulatory effects of bee venom in human synovial fibroblast cell line.

Authors:  Ebrahim Mohammadi; Hossein Vatanpour; Farshad H Shirazi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

Review 8.  Smoking and rheumatoid arthritis.

Authors:  Kathleen Chang; So Min Yang; Seong Heon Kim; Kyoung Hee Han; Se Jin Park; Jae Il Shin
Journal:  Int J Mol Sci       Date:  2014-12-03       Impact factor: 5.923

Review 9.  Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis.

Authors:  Nam Trung Nguyen; Taisuke Nakahama; Chi Hung Nguyen; Trang Thu Tran; Van Son Le; Hoang Ha Chu; Tadamitsu Kishimoto
Journal:  J Exp Pharmacol       Date:  2015-12-01

10.  Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients.

Authors:  Jesús Ogando; Manuel Tardáguila; Andrea Díaz-Alderete; Alicia Usategui; Vanessa Miranda-Ramos; Dannys Jorge Martínez-Herrera; Lorena de la Fuente; María J García-León; María C Moreno; Sara Escudero; Juan D Cañete; María L Toribio; Ildefonso Cases; Alberto Pascual-Montano; José Luis Pablos; Santos Mañes
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.